Our finding of an absence of correlation between Apa1 polymorphism and cervical cancer risk agrees with reports of other studies in prostate, breast and ovarian cancers (Clendenen et al., 2008; Wang et al., 2016). The gene discussed is ZNF410; the disease is ovarian carcinoma.